XRTX Latest Press Releases

-- December 31, 2025 --

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update Globe Newswire 6:15 PM

-- October 29, 2025 --

XORTX Announces Closing of US$1.1 Million Registered Direct Offering Globe Newswire 7:00 AM

-- October 21, 2025 --

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering Globe Newswire 8:00 AM

-- October 20, 2025 --

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency Globe Newswire 8:34 PM

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency Globe Newswire 6:45 PM

-- October 17, 2025 --

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems Globe Newswire 7:00 AM

-- September 4, 2025 --

Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10 Globe Newswire 7:00 AM

-- September 3, 2025 --

XORTX Initiates IND Preparation for XORLO in Gout Program Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software